Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study by Xingxiang Pu, QianZhi Wang, Liyu Liu, Bolin Chen, Kang Li, Yu Zhou, Zengmei Sheng, Ping Liu, Yucheng Tang, Li Xu, Jia Li, Yi Kong, Fang Xu, Yan Xu, Lin Wu

Get full text